Persistent C-reactive protein elevation and incident heart failure in adults at increased cardiovascular risk: A multinational electronic health record study
Abstract
Background: Systemic inflammation has been associated with heart failure (HF) development. C-reactive protein (CRP) is a sensitive marker of inflammation, but its prognostic association with incident HF remains incompletely defined. We explored whether persistent CRP elevation was associated with incident HF among adults at increased cardiovascular (CV) risk.
Methods: We identified 64,743 adults aged 40-80 years from the TriNetX Global Research Network with available body mass index, at least two cardiovascular risk factors, and at least two consecutive CRP measurements within the same predefined range. Participants were categorized as having low (0.1-3.0 mg/L) or elevated CRP (3.1-10.0 mg/L). The primary outcome was incident HF over a maximum follow-up of 10 years. Propensity-score matching was used to balance key baseline characteristics (including CV risk factors).
Results: After matching, each group included 19,547 participants. Elevated CRP was associated with higher risks of incident HF (overall: HR 1.34 [95% CI 1.22-1.48]), all-cause mortality (HR 1.90 [95% CI, 1.67-2.17]), and their composite (HR 1.49 [95% CI 1.37-1.62]). In exploratory phenotype-specific analyses, directionally consistent associations were observed for code-defined HFrEF (HR, 1.53; 95% CI, 1.30-1.80) and HFpEF (HR, 1.44; 95% CI, 1.24-1.66). Exploratory subgroup analyses suggested a stronger association among participants without obesity (P for heterogeneity =0.004).
Conclusions:In this selected cohort of adults at increased CV risk, persistent CRP elevation was associated with higher risk of incident HF and all-cause mortality. These findings may suggest the prognostic relevance of elevated CRP and warrant further study of inflammation in HF development.
Related
- Persistent Apical Akinesis Following Takotsubo Syndrome With Marked Troponin Elevation: A Case Report
- Profiling perceived knowledge, relevance and interest across geriatric topics of health and social care professionals: multinational electronic cross-sectional survey.
- Electronic health record–observed lithium persistence after within-service initiation in bipolar disorder: an incident-initiator cohort study from a multinational tertiary psychiatric service in the United Arab Emirates
- Solving the mystery of persistent isolated aspartate aminotransferase elevation: Macro-AST as a decisive diagnostic consideration
- Triglyceride-glucose index and risk of major adverse cardiovascular events in ST-segment elevation myocardial infarction patients undergoing primary percutaneous coronary intervention
BibTeX
@article{busti2026persistent,
title = {{Persistent C-reactive protein elevation and incident heart failure in adults at increased cardiovascular risk: A multinational electronic health record study}},
author = {Matteo Busti and Luca Monzo and Tripti Rastogi and Carolyn S.P. Lam and Gianluigi Savarese and Deepak L Bhatt and Marat Fudim and Guillaume Baudry and Nicolas Girerd},
journal = {International Journal of Cardiology},
year = {2026},
month = sep,
doi = {10.1016/j.ijcard.2026.134934},
url = {https://hal.univ-lorraine.fr/hal-05753357v1},
note = {CC BY 4.0},
}
RIS
TY - JOUR
TI - Persistent C-reactive protein elevation and incident heart failure in adults at increased cardiovascular risk: A multinational electronic health record study
AU - Matteo Busti
AU - Luca Monzo
AU - Tripti Rastogi
AU - Carolyn S.P. Lam
AU - Gianluigi Savarese
AU - Deepak L Bhatt
AU - Marat Fudim
AU - Guillaume Baudry
AU - Nicolas Girerd
PY - 2026
DA - 2026/09/17
JO - International Journal of Cardiology
DO - 10.1016/j.ijcard.2026.134934
UR - https://hal.univ-lorraine.fr/hal-05753357v1
AB - Background: Systemic inflammation has been associated with heart failure (HF) development. C-reactive protein (CRP) is a sensitive marker of inflammation, but its prognostic association with incident HF remains incompletely defined. We explored whether persistent CRP elevation was associated with incident HF among adults at increased cardiovascular (CV) risk. Methods: We identified 64,743 adults aged 40-80 years from the TriNetX Global Research Network with available body mass index, at least two cardiovascular risk factors, and at least two consecutive CRP measurements within the same predefined range. Participants were categorized as having low (0.1-3.0 mg/L) or elevated CRP (3.1-10.0 mg/L). The primary outcome was incident HF over a maximum follow-up of 10 years. Propensity-score matching was used to balance key baseline characteristics (including CV risk factors). Results: After matching, each group included 19,547 participants. Elevated CRP was associated with higher risks of incident HF (overall: HR 1.34 [95% CI 1.22-1.48]), all-cause mortality (HR 1.90 [95% CI, 1.67-2.17]), and their composite (HR 1.49 [95% CI 1.37-1.62]). In exploratory phenotype-specific analyses, directionally consistent associations were observed for code-defined HFrEF (HR, 1.53; 95% CI, 1.30-1.80) and HFpEF (HR, 1.44; 95% CI, 1.24-1.66). Exploratory subgroup analyses suggested a stronger association among participants without obesity (P for heterogeneity =0.004). Conclusions:In this selected cohort of adults at increased CV risk, persistent CRP elevation was associated with higher risk of incident HF and all-cause mortality. These findings may suggest the prognostic relevance of elevated CRP and warrant further study of inflammation in HF development.
SN - 0167-5273
SN - 1874-1754
ER -